IMPEL NEUROPHARMA INC's ticker is IMPL and the CUSIP is 45258K109. A total of 2 filers reported holding IMPEL NEUROPHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 109 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 109 | +45.3% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 75 | -82.4% | 0.00% | – |
| Q1 2022 | $3,000 | -76.9% | 426 | -70.2% | 0.00% | – |
| Q4 2021 | $13,000 | +62.5% | 1,431 | +102.7% | 0.00% | – |
| Q3 2021 | $8,000 | +166.7% | 706 | +90.8% | 0.00% | – |
| Q2 2021 | $3,000 | – | 370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 2,759,791 | $340,834 | 0.05% |
| ST GERMAIN D J CO INC | 1,500 | $185 | 0.00% |